(Q80030336)

English

MF59-adjuvanted influenza vaccine confers superior immunogenicity in adult subjects (18-60 years of age) with chronic diseases who are at risk of post-influenza complications

scientific article published on 06 March 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17383057%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

MF59-adjuvanted influenza vaccine confers superior immunogenicity in adult subjects (18-60 years of age) with chronic diseases who are at risk of post-influenza complications (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17383057%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

influenza vaccine

1 reference

based on heuristic

inferred from title

0 references

Tatjana Baldovin

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17383057%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17383057%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

author name string

V Baldo

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17383057%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

A Floreani

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17383057%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

A M Carraro

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17383057%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

R Trivello

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17383057%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

publication date

6 March 2007

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17383057%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17383057%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

25

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17383057%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

20

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17383057%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

3955-3961

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17383057%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Influenza-associated hospitalizations in the United States

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.045

7 January 2021

Influenza vaccination coverage and reasons to refrain among high-risk persons in four European countries

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.045

7 January 2021

Comparison of three different influenza vaccines in institutionalised elderly

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.045

7 January 2021

Comparison of the reactogenicity and immunogenicity of a split and a subunit-adjuvanted influenza vaccine in elderly subjects.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.045

7 January 2021

Influenza vaccines: antibody responses to split virus and MF59-adjuvanted subunit virus in an adult population.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.045

7 January 2021

Antibody response to influenza vaccination in the elderly: a quantitative review

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.045

7 January 2021

Seroprotection rate, mean fold increase, seroconversion rate: which parameter adequately expresses seroresponse to influenza vaccination?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.045

7 January 2021

A history of influenza

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.045

7 January 2021

Protection against influenza after annually repeated vaccination: a meta-analysis of serologic and field studies.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.045

7 January 2021

Impact of influenza vaccination on seasonal mortality in the US elderly population.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.045

7 January 2021

An MF59-adjuvanted inactivated influenza vaccine containing A/Panama/1999 (H3N2) induced broader serological protection against heterovariant influenza virus strain A/Fujian/2002 than a subunit and a split influenza vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.045

7 January 2021

Effects of repeated annual influenza vaccination on vaccine sero-response in young and elderly adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.045

7 January 2021

Clinical effectiveness of influenza vaccination in persons younger than 65 years with high-risk medical conditions: the PRISMA study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.045

7 January 2021

Safety and immunogenicity of MF59-adjuvanted influenza vaccine in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.045

7 January 2021

Comparison of the safety, tolerability, and immunogenicity of a MF59-adjuvanted influenza vaccine and a non-adjuvanted influenza vaccine in non-elderly adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.045

7 January 2021

Evidence of increased clinical protection of an MF59-adjuvant influenza vaccine compared to a non-adjuvant vaccine among elderly residents of long-term care facilities in Italy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.045

7 January 2021

Identifiers

10.1016/J.VACCINE.2007.02.045

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17383057%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17383057%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q80030336&oldid=2005232732"